TIGIT and hepatocellular carcinoma: Based on the above results of mass spectrometry that Apoe deficiency enhanced the expression of PD-1 and TIGIT in CRC, we tried to treat cancers combination with these two antibodies (αPD-1/αTIGIT) in three types of cancer (CRC, GC and HCC).